Kidney Imaging Surveillance in Commercially Insured Patients With Tuberous Sclerosis Complex.

[1]  R. Touraine,et al.  Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  O. Rouvière,et al.  Renal manifestations of tuberous sclerosis complex: patients’ and parents’ knowledge and routines for renal follow-up – a questionnaire study , 2018, BMC Nephrology.

[3]  B. Korf,et al.  Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related Angiomyolipomas. , 2017, Urology.

[4]  J. Bissler,et al.  Long-term Clinical Morbidity in Patients With Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex. , 2016, Urology.

[5]  P. Nasuti,et al.  The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD) , 2016, Journal of medical economics.

[6]  B. Korf,et al.  Epilepsy treatment patterns among patients with tuberous sclerosis complex , 2016, Journal of the Neurological Sciences.

[7]  P. Bolton,et al.  The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD). , 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[8]  M. Eijkemans,et al.  Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  D. Krueger,et al.  Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference , 2013, Pediatric neurology.

[10]  M. Kohrman,et al.  Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis , 2012, Current medical research and opinion.

[11]  C. Martyn,et al.  An epidemiological study of renal pathology in tuberous sclerosis complex , 2004, BJU international.

[12]  J. Bissler,et al.  Tuberous sclerosis complex: renal imaging findings. , 2002, Radiology.

[13]  K. Takeda,et al.  Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. , 2002, Radiology.

[14]  H. Northrup,et al.  Tuberous Sclerosis Consensus Conference: Recommendations for Diagnostic Evaluation , 1999, Journal of child neurology.

[15]  J. Osborne,et al.  End-stage renal failure in adults with the tuberous sclerosis complex. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  T. Hensle,et al.  The tuberous sclerosis complex: a comprehensive review. , 1998, Journal of the American College of Surgeons.

[17]  M. Delgado,et al.  Renal lesion growth in children with tuberous sclerosis complex. , 1998, The Journal of urology.

[18]  M. Dickinson,et al.  Renal angiomyolipoma: optimal treatment based on size and symptoms. , 1998, Clinical nephrology.

[19]  J. Sampson,et al.  A cross sectional study of renal involvement in tuberous sclerosis. , 1996, Journal of medical genetics.

[20]  J. Osborne,et al.  MORBIDITY ASSOCIATED WITH TUBEROUS SCLEROSIS: A POPULATION STUDY , 1996, Developmental medicine and child neurology.

[21]  H. Neumann,et al.  Tuberous sclerosis complex with end-stage renal failure. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  S. Verhoef,et al.  The evolution of renal angiomyolipomas in patients with tuberous sclerosis. , 1994, The Journal of urology.

[23]  C. Crowson,et al.  Causes of death in patients with tuberous sclerosis. , 1991, Mayo Clinic proceedings.

[24]  J. Osborne,et al.  Epidemiology of Tuberous Sclerosis , 1991, Annals of the New York Academy of Sciences.

[25]  E. Fishman,et al.  The management of renal angiomyolipoma. , 1986, The Journal of urology.

[26]  B. McCoy,et al.  A Review of Investigations for Patients With Tuberous Sclerosis Complex Who Were Referred to the Tuberous Sclerosis Clinic at The Hospital for Sick Children: Identifying Gaps in Surveillance. , 2019, Pediatric neurology.

[27]  J. Bissler,et al.  Renal angiomyolipomata. , 2004, Kidney international.

[28]  D. Kwiatkowski,et al.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. , 2001, American journal of human genetics.